Results 11 to 20 of about 908,735 (292)

Antiarrhythmic Properties of Beta Blockers: Focus on Nebivolol [PDF]

International Journal of the Cardiovascular Academy
Beta-blockers are commonly used medications for cardiovascular diseases. Beta-blockers are effective antiarrhythmic agents, and they are class 2 agents in the Vaughan-Williams classification.
Bülent Görenek, Ali Nazmi Çalık, Alper Kepez, Ahmet Öz, Çağlar Özmen, Ümit Yaşar Sinan, Osman Can Yontar, Çağan Yıldırım   +7 more
doaj   +2 more sources

Beta-blockers in Cardiovascular Therapy: A Review [PDF]

Journal of Mind and Medical Sciences, 2019
The role of beta-adrenergic receptor antagonists in cardiovascular therapy has been the subject of various studies over time, these agents representing one of the oldest class of drugs used for the treatment of cardiovascular diseases.
Camelia C. Diaconu, Dragos R. Marcu, Ovidiu G. Bratu, Ana Maria A. Stanescu, Gina Gheorghe, Andreea A. Hlescu, Dan LD. Mischianu, Maria Manea   +7 more
doaj   +2 more sources

Impact of beta2-agonists, beta-blockers, and their combination on cardiac function in elderly male patients with chronic obstructive pulmonary disease

Clinical Interventions in Aging, 2013
Long-Huan Zeng,1,* Yi-Xin Hu,2,* Lin Liu,2 Meng Zhang,1 Hua Cui1 1Second Geriatric Cardiology Division, 2Clinical Department of Geriatrics, Chinese PLA General Hospital, Beijing, People's Republic of China *These authors contributed equally to this ...
Zeng LH, Hu YX, Liu L, Zhang M, Cui H
doaj   +1 more source

The effect of beta blockers on heart rate response during the Chester Step Test [PDF]

, 2011
The objective of this study is to ascertain that as the intensity of exercise increases through the stages of the Chester Step Test (CST) does the difference between the beta blocked(BB) and the non beta blocked(NBB) participants heart rate(HR) response ...
Gilchrest, Joanne
core   +2 more sources

Inappropriate use of beta-blockers among medical and dental students at King Saud University, Riyadh

Journal of Family Medicine and Primary Care, 2020
Aim: Self-medication and inappropriate beta-blocker use have been commonly reported among students. This study aimed to determine the prevalence of inappropriate self-prescription of beta-blockers among medical and dental students.
Abdulelah Adnan Abukhalaf, Ali Abdullah Alomar, Nayef Mosleh Alsalame, Omar Yassin Sumaya, Omar Mohammed Alessa, Majed Mohammed Alasbali, Yasser A Alaska   +6 more
doaj   +1 more source

BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE

Рациональная фармакотерапия в кардиологии, 2015
Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented. The role of beta-blockers among other basic groups of antihypertensive drugs (thiazide diuretics, calcium channel blockers, ACE inhibitors) is evaluated ...
M. V. Leonova
doaj   +3 more sources

Differing effects of beta-blockers on long-term clinical outcomes following percutaneous coronary intervention between patients with mid-range and reduced left ventricular ejection fraction

BMC Cardiovascular Disorders, 2021
Background The aim of this study was to determine the difference in effects of beta-blockers on long-term clinical outcomes between ischemic heart disease (IHD) patients with mid-range ejection fraction (mrEF) and those with reduced ejection fraction ...
Jun Shitara, Ryo Naito, Takatoshi Kasai, Hirohisa Endo, Hideki Wada, Shinichiro Doi, Hirokazu Konishi, Shuta Tsuboi, Manabu Ogita, Tomotaka Dohi, Shinya Okazaki, Katsumi Miyauchi, Hiroyuki Daida   +12 more
doaj   +1 more source

Effect of beta-blockers on exacerbation rate and lung function in chronic obstructive pulmonary disease (COPD)

Respiratory Research, 2017
Background Beta-blockers are commonly prescribed for patients with cardiovascular disease. Providers have been wary of treating chronic obstructive pulmonary disease (COPD) patients with beta-blockers due to concern for bronchospasm, but retrospective ...
Sean Duffy, Robert Marron, Helen Voelker, Richard Albert, John Connett, William Bailey, Richard Casaburi, J. Allen Cooper, Jeffrey L. Curtis, Mark Dransfield, MeiLan K. Han, Barry Make, Nathaniel Marchetti, Fernando Martinez, Stephen Lazarus, Dennis Niewoehner, Paul D. Scanlon, Frank Sciurba, Steven Scharf, Robert M. Reed, George Washko, Prescott Woodruff, Charlene McEvoy, Shawn Aaron, Don Sin, Gerard J. Criner, the NIH COPD Clinical Research Network and the Canadian Institutes of Health Research   +26 more
doaj   +1 more source

Drug Use Evaluation of Beta-Blockers in Medical Wards of Nedjo General Hospital, Western Ethiopia

Cardiovascular Therapeutics, 2020
Introduction. Beta-blocker use evaluation is a performance method that focuses on the evaluation of beta-blocker use processes to achieve optimal patient outcomes.
Ginenus Fekadu, Firomsa Bekele, Kumera Bekele, Sagni Hanbisa, Gemechis Belay, Mudasir Maqbool   +5 more
doaj   +1 more source

Impact of reimbursement program “Аffordable Medicines” on consumptiom of betablockers in Ukraine in 2017-2020

Ukrainian Scientific Medical Youth Journal, 2022
the article presents the results of the study of impact of the reimbursement program “Affordable medicines” on consumption of beta-blockers in Ukraine, used for treatment of cardiovascular diseases.
Anton Gonchar, Natalia Sholoiko
doaj   +1 more source